Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for STRATTERA
- Enhancing the Effects of Adolescent Alcohol Treatment With Atomoxetine
- A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
- The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic Study
- A Novel Pharmacological Therapy for Obstructive Sleep Apnea
- Orthostatic Intolerance After Bariatric Surgery
- Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS)
- Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
- The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
- Post-stroke Neural Plasticity With Atomoxetine
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)
- Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers
- Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
- EAA/Therapy for Treating Children With ADHD
- Effects of Atx and Oros-mph on Executive Functions
- Atomoxetine in Veterans With Comorbid ADHD/PTSD
- Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
- ADHD Medication and Predictors of Treatment Outcome
- Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers
- Safety Study to Assess Atomoxetine With MA Abusers and Healthy Controls
- Changes in Striatal [11C]ORM-13070 Binding Elicited by Changing Levels of Endogenous Noradrenaline
- Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)
- Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach
- Clinical Efficacy of Atomoxetine for Methamphetamine Dependence
- Effects of Atomoxetine in Mild Cognitive Impairment
- Cognitive Effects of Atomoxetine in Humans: Genetic Moderators
- Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline
- A Dose Response Effect of Atomoxetine to the Acute Effects of Alcohol
- Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits
- A Gene by Medication Interaction to the Acute Effects of Alcohol
- Cognitive Decline in Non-demented PD
- Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
- Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
- A Bioequivalence (BE) Study in Healthy Subjects
- Interventions for Children With Attention and Reading Disorders
- A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate
- Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children
- Safety Assessment of Atomoxetine With MA IV Administration
- A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder
- Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD
- Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder
- Atomoxetine, Placebo and Parent Management Training in Autism
- Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine
- Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)
- Efficacy Study of Strattera for Treating Attention Disorders in Traumatic Brain Injury (TBI)
- A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Agonist Replacement Therapy for Cocaine Dependence
- Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE
- Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Safety Study of Atomoxetine and Cerebrovascular Outcomes
- Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation
- Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial
- Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women
- Treatment of Orthostatic Hypotension
- Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
- ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD
- The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
- Treatment Compliance in Children and Adolescents on ADHD Medication
- Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)
- Atomoxetine Pilot Study in Preschool Children With ADHD
- Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes
- Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD
- Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism
- Evaluation of Continuous Symptom Treatment of ADHD
- A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine
- A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents
- Effects of Atomoxetine on Cognitive Function in Schizophrenia
- Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
- Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany
- Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder
- Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder
- Atomoxetine and Huntington's Disease
- Atomoxetine Treatment for ADHD and Marijuana Dependence
- Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison
- Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Treatment of Executive Dysfunction in Parkinson's Disease
- Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1
- Treatment of Orthostatic Intolerance
- Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder
- Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children
- Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents
- Treatment of Orthostatic Hypotension in Autonomic Failure
- A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia
- An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).
- Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)
- Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)
- Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD
- Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)
- A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Long-Term, Open Label Atomoxetine Study
- Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy
- Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)
- Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar
Clinical trials list
click for details